Rossari Biotech Subsidiary Sells Mumbai Office Premises for Rs 10 Crores

Rossari Biotech Limited has announced that its material subsidiary, Unitop Chemicals Private Limited, has approved the sale of office premises in Mumbai for Rs 10 crores. The transaction was approved by the subsidiary's Board of Directors on April 03, 2026, marking a significant asset divestment for the group.

The subsidiary has agreed to sell its office premises located at Saki Naka, Mumbai, at a consideration of approximately Rs 10 crores (Rupees Ten Crore only). The proposed transaction is expected to reach completion by the end of Q2 FY27, providing a clear timeline for the asset disposal.

The company has provided assurance regarding the transaction's impact on business operations. As no business operations are currently conducted from the premises proposed to be sold by the subsidiary, the sale will not have any impact on either the company's or subsidiary's business operations. This strategic decision appears to be focused on asset optimization rather than operational restructuring.

The disclosure has been made pursuant to Regulation 30(9) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that the sale of the premises does not constitute the sale of an undertaking within the meaning of Section 180(1)(a) of the Companies Act, 2013. Additional details required under Regulation 30 of the Listing Regulations, as per SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, will be provided upon execution of the agreement. This ensures full regulatory compliance throughout the transaction process.

Unitop Chemicals Private Limited operates as a material subsidiary of Rossari Biotech Limited, making this transaction significant enough to warrant disclosure under regulatory requirements. The parent company maintains its registered office at Rossari House, Golden Oak, LBS Marg, Surya Nagar, Vikhroli (West), Mumbai, with manufacturing facilities in Silvassa and Gujarat.

Historical stock returns for Rossari Biotech show a mixed performance over different time periods. Over the past day, the stock has gained 5.89%, and over the past five days, it has risen by 3.07%. However, over the past month, the stock has declined by 13.73%, and over the past six months, it has dropped by 32.70%. Over the past year, the stock has fallen by 30.50%, and over the past five years, it has declined by 60.12%.